Cardiovascular Risk Calculation: D (>30%)
Based on the patient profile provided (71-year-old male, non-smoker, no diabetes, BP 171/90 mmHg, total cholesterol 6.1 mmol/L [236 mg/dL], HDL-C 1.0 mmol/L [39 mg/dL]), the 10-year cardiovascular disease risk exceeds 30%, placing this patient in the highest risk category.
Risk Assessment Rationale
This patient has multiple high-risk features that compound to produce very high cardiovascular risk:
Age 71 years: The patient is beyond the typical risk calculator age range (40-75 years) used in most guidelines 1, 2. Notably, the 2017 USPSTF guidelines explicitly state that for adults 76 years and older, there is insufficient evidence to make recommendations 1, but this reflects uncertainty about treatment benefit, not low risk. The 2019 ACC/AHA guidelines note that a 65-year-old man with optimal risk factors reaches a 7.5% 10-year risk threshold 3, and risk increases exponentially with age.
Severe hypertension (171/90 mmHg): Stage 2 hypertension with systolic BP >170 mmHg is a major risk multiplier. The patient is untreated, meaning this represents true baseline risk without medication effect 4.
Dyslipidemia: Total cholesterol 6.1 mmol/L (236 mg/dL) with HDL-C 1.0 mmol/L (39 mg/dL) represents significant atherogenic dyslipidemia. The HDL-C is below the risk-enhancing threshold of <40 mg/dL for men 2.
Total cholesterol/HDL-C ratio: This ratio is 6.1, which is markedly elevated and strongly predictive of cardiovascular events 5.
Evidence-Based Risk Estimation
The ACC/AHA Pooled Cohort Equations are recommended for calculating 10-year ASCVD risk 1, 2, 4. While I cannot access the referenced picture, applying the Pooled Cohort Equations to this profile:
A 71-year-old male with these parameters (untreated systolic BP 171 mmHg, total cholesterol 236 mg/dL, HDL-C 39 mg/dL, non-smoker, non-diabetic) would generate a 10-year ASCVD risk well above 30%.
The 2019 ACC/AHA guidelines note that age alone drives substantial risk, with a 65-year-old man with optimal risk factors already reaching 7.5% risk 3. This patient is 6 years older with multiple adverse risk factors.
Research examining the PREVENT equations (the newest risk calculator) shows that a male with average risk factors reaches 7.5% risk at age 63 years 6. This patient has significantly worse-than-average risk factors at age 71.
Clinical Implications
This patient requires immediate intensive risk reduction therapy:
Statin therapy: High-intensity statin is indicated to reduce LDL-C by ≥50% 2. The 2019 ACC/AHA guidelines recommend starting statin therapy without calculating risk in patients with severe primary hypercholesterolemia or multiple risk factors 2.
Antihypertensive therapy: Immediate initiation is recommended given BP 171/90 mmHg. The 2025 AHA/ACC guidelines recommend treatment when SBP ≥130 mmHg in patients at increased CVD risk (≥7.5% 10-year risk) 7, which this patient far exceeds.
Aspirin consideration: For secondary prevention if any subclinical disease is detected, though primary prevention aspirin is more controversial.
Important Caveats
Age >75 years: The USPSTF notes insufficient evidence for statin initiation in adults >76 years 1, but this reflects lack of trial data, not absence of risk. This patient is 71 years old, still within the evidence-supported age range.
Risk calculator limitations: Most calculators are validated for ages 40-75 years 3, 4. However, cardiovascular risk continues to increase with age, and this patient's risk factors would place him at very high risk even at age 75.
Competing risks: At age 71, non-cardiovascular mortality becomes more relevant, but with no mentioned comorbidities, cardiovascular prevention remains paramount for both mortality and quality of life.
The answer is D (>30%) based on the combination of advanced age, severe untreated hypertension, and significant dyslipidemia 2, 4.